LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD, Inc. (NASDAQ: LFMD) was upgraded by analysts at B. Riley to a "strong-buy" rating.
LifeMD, Inc. (NASDAQ: LFMD) had its price target raised by analysts at HC Wainwright from $12.00 to $14.00. They now have a "buy" rating on the stock.
LifeMD, Inc. (NASDAQ: LFMD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $15.00 price target on the stock.